PRCT — PROCEPT BioRobotics Share News
0.000.00%
Last trade - 00:00- $1.04bn
- $863.32m
- $308.05m
Brief: Procept Biorobotics Q4 revenue USD 23.8 million
Procept Biorobotics Corp Reports Results For The Quarter Ended In December: Earnings Summary
Brief: Procept Biorobotics Reports Fourth Quarter And Full Year 2022 Results
Procept Biorobotics Corp Expected To Post A Loss Of 54 Cents A Share: Earnings Preview
Brief: Procept Biorobotics Says Total Q4 2022 Revenue Is Expected To Be In The Range Of $23.6 Mln To $23.8 Mln
Brief: Procept Biorobotics Announces $52 Million Debt Refinancing
Brief: Providence Advances Surgical Robotics Program With Multi-System, National Contract For Procept Biorobotics Aquabeam Systems
Brief: Procept Biorobotics Reports Q2 Results And Increases 2022 Revenue Guidance
Brief: PROCEPT BioRobotics Corp Reports Aetna and Independence Blue Cross Blue Shield Positive Coverage Decisions Regarding Aquablation Therapy
Medical device makers likely to give conservative outlook in Q1 - SVB Leerink
Procept Biorobotics surges on strong revenue, forecast
Brief: Procept Announces 5-Year Water Study Data Comparing Aquablation TURP
Brief: Procept Biorobotics Corp Now Has Five Aquabeam Robotic Systems Installed Across All Of Northside Health Systems' Surgical Facilities
Brief: Procept Biorobotics Corp Announces Preliminary Q4 And Fiscal Year 2021 Revenue
Brief: PROCEPT BioRobotics Appoints Mary Garrett to Board of Directors
Brief: Procept Biorobotics Appoints Elisabeth Sandoval To Board Of Directors
Brief: Procept Biorobotics Corp Announces Cigna Adds Aquablation Therapy To Its Coverage Policy
Live Markets: IPO market off to the races
U.S. STOCKS ON THE MOVE-Indaptus Therapeutics, Kaival Brands, GreenSky